How to buy LianBio stock

LianBio ADR is a biotechnology business based in the US. LianBio shares (LIAN) are listed on the NASDAQ and all prices are listed in US Dollars. LianBio employs 107 staff and has a market cap (total outstanding shares value) of 0.00.

Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

LianBio stock price (NASDAQ: LIAN)

Use our graph to track the performance of LIAN stocks over time.

LianBio shares at a glance

• Key figures

Information last updated 2022-07-04.

Latest market close	$2.28
52-week range	$2.10 - $16.37
50-day moving average more info button	$2.92
200-day moving average more info button	$5.71
Wall St. target price	$15.78
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-2.90

Buy LianBio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy LianBio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

LianBio price performance over time

Historical closes compared with the close of $2.28 from 2022-07-01

1 week (2022-06-28)	3.64%
1 month (2022-06-03)	-21.38%
3 months (2022-04-05)	-54.12%
6 months (2022-01-05)	-58.32%

1 year (2021-07-01)	N/A
2 years (2020-07-01)	N/A
3 years (2019-07-01)	N/A
5 years (2017-07-01)	N/A

LianBio financials

Gross profit TTM	$0
Return on assets TTM	-48.88%
Return on equity TTM	-52.71%
Profit margin	0%
Book value	$3.09
Market capitalisation more info button	$246.9 million

TTM: trailing 12 months

LianBio share dividends

We're not expecting LianBio to pay a dividend over the next 12 months.

You may also wish to consider:

• AbbVie (ABBV.US) (3.68% forward annual dividend yield)
• BioNTech (BNTX.US) (1.33% forward annual dividend yield)
• Novartis AG ADR (NVS.US) (3.94% forward annual dividend yield)

LianBio overview

LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with preserved ejection fraction; TP-03 for the treatment of Demodex blepharitis; NBTXR3 for the treatment of head and neck squamous cell carcinoma, and solid tumor; Infigratinib for the treatment of second-line and first-line cholangiocarcinoma, and gastric cancers; BBP-398 for solid tumors; Omilancor for ulcerative colitis and Crohn's disease; NX-13 for ulcerative colitis; LYR-210 for chronic rhinosinusitis; and Sisunatovir for respiratory syncytical virus. It has a partnership with Tarsus Pharmaceuticals, Inc. to develop and commercialize TP-03, an eye solution for the treatment of Demodex blepharitis; and Nanobiotix S. A. to develop and commercialize NBTXR3, a radioenhancer designed to be injected directly into a malignant tumor prior to standard radiotherapy. The company was incorporated in 2019 and is headquartered in Princeton, New Jersey.

Frequently asked questions

What percentage of LianBio is owned by insiders or institutions?
Currently 5.864% of LianBio shares are held by insiders and 79.707% by institutions. How many people work for LianBio?
Latest data suggests 107 work at LianBio. When does the fiscal year end for LianBio?
LianBio's fiscal year ends in December. Where is LianBio based?
LianBio's address is: 103 Carnegie Center Drive, Princeton, NJ, United States, 08540 What is LianBio's ISIN number?
LianBio's international securities identification number is: US53000N1081